Details for New Drug Application (NDA): 011284
✉ Email this page to a colleague
NDA 011284 describes MEPROSPAN, which is a drug marketed by Medpointe Pharm Hlc and is included in one NDA. Additional details are available on the MEPROSPAN profile page.
The generic ingredient in MEPROSPAN is meprobamate. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the meprobamate profile page.
The generic ingredient in MEPROSPAN is meprobamate. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the meprobamate profile page.
Summary for 011284
| Tradename: | MEPROSPAN |
| Applicant: | Medpointe Pharm Hlc |
| Ingredient: | meprobamate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 011284
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 200MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 400MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
